Loading clinical trials...
Loading clinical trials...
Effect of Ursodeoxycholic Acid Supplementation on Liver Regeneration on Right Lobe Donor Hepatectomy: An Open Label Randomised Trial
Conditions
Interventions
Ursodeoxycholic acid
Standard Medical Treatment
Locations
1
India
Institute of Liver and Biliary Sciences
New Delhi, India
Start Date
September 1, 2023
Primary Completion Date
November 30, 2024
Completion Date
November 30, 2024
Last Updated
December 24, 2025
NCT06604923
NCT02945059
NCT04178759
NCT03213314
NCT03489889
NCT01700231
Lead Sponsor
Institute of Liver and Biliary Sciences, India
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions